ID: ALA5081803

Max Phase: Preclinical

Molecular Formula: C18H23F2N

Molecular Weight: 291.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C(F)F)cc13

Standard InChI:  InChI=1S/C18H23F2N/c1-21-9-8-18-7-3-2-4-14(18)16(21)11-12-5-6-13(17(19)20)10-15(12)18/h5-6,10,14,16-17H,2-4,7-9,11H2,1H3/t14-,16+,18+/m1/s1

Standard InChI Key:  ISRLNSUYNQXWKJ-HFTRVMKXSA-N

Associated Targets(Human)

Norepinephrine transporter 10102 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin transporter 12625 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate [NMDA] receptor 933 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma intracellular receptor 2 973 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma opioid receptor 6358 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.38Molecular Weight (Monoisotopic): 291.1799AlogP: 4.31#Rotatable Bonds: 1
Polar Surface Area: 3.24Molecular Species: BASEHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.87CX LogP: 4.04CX LogD: 1.60
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.74Np Likeness Score: 0.75

References

1. Sorrentino JP, Altman RA..  (2022)  Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability.,  13  (4.0): [PMID:35450379] [10.1021/acsmedchemlett.2c00055]

Source